Modeling the effects of prior infection on vaccine efficacy

Derek J. Smith, Stephanie Forrest, David H. Ackley, Alan S. Perelson

Research output: Contribution to journalConference article

6 Citations (Scopus)

Abstract

We performed computer simulations to study the effects of prior infection on vaccine efficacy. We injected three antigens sequentially. The first antigen, designated the prior, represented a prior infection or vaccination. The second antigen, the vaccine, represented a single component of the trivalent influenza vaccine. The third antigen, the epidemic, represented challenge by an epidemic strain. For a fixed vaccine to epidemic strain cross-reactivity, we generated prior strains over a full range of cross-reactivities to the vaccine and to the epidemic strains. We found that, for many cross-reactivities, vaccination, when it had been preceded by a prior infection, provided more protection than vaccination alone. However, at some cross-reactivities, the prior infection reduced protection by clearing the vaccine before it had the chance to produce protective memory. The cross-reactivities between the prior, vaccine and epidemic strains played a major role in determining vaccine efficacy. This work has applications to understanding vaccination against viruses such as influenza that are continually mutating.

Original languageEnglish (US)
Pages (from-to)363-368
Number of pages6
JournalProceedings of the IEEE International Conference on Systems, Man and Cybernetics
Volume1
StatePublished - Dec 1 1997
Externally publishedYes
EventProceedings of the 1997 IEEE International Conference on Systems, Man, and Cybernetics. Part 1 (of 5) - Orlando, FL, USA
Duration: Oct 12 1997Oct 15 1997

Fingerprint

Vaccines
Antigens
Viruses
Data storage equipment
Computer simulation

ASJC Scopus subject areas

  • Control and Systems Engineering
  • Hardware and Architecture

Cite this

Modeling the effects of prior infection on vaccine efficacy. / Smith, Derek J.; Forrest, Stephanie; Ackley, David H.; Perelson, Alan S.

In: Proceedings of the IEEE International Conference on Systems, Man and Cybernetics, Vol. 1, 01.12.1997, p. 363-368.

Research output: Contribution to journalConference article

@article{c7bff675744c49b79e18293942eae2c1,
title = "Modeling the effects of prior infection on vaccine efficacy",
abstract = "We performed computer simulations to study the effects of prior infection on vaccine efficacy. We injected three antigens sequentially. The first antigen, designated the prior, represented a prior infection or vaccination. The second antigen, the vaccine, represented a single component of the trivalent influenza vaccine. The third antigen, the epidemic, represented challenge by an epidemic strain. For a fixed vaccine to epidemic strain cross-reactivity, we generated prior strains over a full range of cross-reactivities to the vaccine and to the epidemic strains. We found that, for many cross-reactivities, vaccination, when it had been preceded by a prior infection, provided more protection than vaccination alone. However, at some cross-reactivities, the prior infection reduced protection by clearing the vaccine before it had the chance to produce protective memory. The cross-reactivities between the prior, vaccine and epidemic strains played a major role in determining vaccine efficacy. This work has applications to understanding vaccination against viruses such as influenza that are continually mutating.",
author = "Smith, {Derek J.} and Stephanie Forrest and Ackley, {David H.} and Perelson, {Alan S.}",
year = "1997",
month = "12",
day = "1",
language = "English (US)",
volume = "1",
pages = "363--368",
journal = "Proceedings of the IEEE International Conference on Systems, Man and Cybernetics",
issn = "0884-3627",
publisher = "Institute of Electrical and Electronics Engineers Inc.",

}

TY - JOUR

T1 - Modeling the effects of prior infection on vaccine efficacy

AU - Smith, Derek J.

AU - Forrest, Stephanie

AU - Ackley, David H.

AU - Perelson, Alan S.

PY - 1997/12/1

Y1 - 1997/12/1

N2 - We performed computer simulations to study the effects of prior infection on vaccine efficacy. We injected three antigens sequentially. The first antigen, designated the prior, represented a prior infection or vaccination. The second antigen, the vaccine, represented a single component of the trivalent influenza vaccine. The third antigen, the epidemic, represented challenge by an epidemic strain. For a fixed vaccine to epidemic strain cross-reactivity, we generated prior strains over a full range of cross-reactivities to the vaccine and to the epidemic strains. We found that, for many cross-reactivities, vaccination, when it had been preceded by a prior infection, provided more protection than vaccination alone. However, at some cross-reactivities, the prior infection reduced protection by clearing the vaccine before it had the chance to produce protective memory. The cross-reactivities between the prior, vaccine and epidemic strains played a major role in determining vaccine efficacy. This work has applications to understanding vaccination against viruses such as influenza that are continually mutating.

AB - We performed computer simulations to study the effects of prior infection on vaccine efficacy. We injected three antigens sequentially. The first antigen, designated the prior, represented a prior infection or vaccination. The second antigen, the vaccine, represented a single component of the trivalent influenza vaccine. The third antigen, the epidemic, represented challenge by an epidemic strain. For a fixed vaccine to epidemic strain cross-reactivity, we generated prior strains over a full range of cross-reactivities to the vaccine and to the epidemic strains. We found that, for many cross-reactivities, vaccination, when it had been preceded by a prior infection, provided more protection than vaccination alone. However, at some cross-reactivities, the prior infection reduced protection by clearing the vaccine before it had the chance to produce protective memory. The cross-reactivities between the prior, vaccine and epidemic strains played a major role in determining vaccine efficacy. This work has applications to understanding vaccination against viruses such as influenza that are continually mutating.

UR - http://www.scopus.com/inward/record.url?scp=0031373337&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031373337&partnerID=8YFLogxK

M3 - Conference article

AN - SCOPUS:0031373337

VL - 1

SP - 363

EP - 368

JO - Proceedings of the IEEE International Conference on Systems, Man and Cybernetics

JF - Proceedings of the IEEE International Conference on Systems, Man and Cybernetics

SN - 0884-3627

ER -